Approval · Notice of Compliance 2537 · 2001
PROCAN SR TABLETS: Notice of Compliance 2537
Issued January 24, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2537
- Date
- January 24, 2001
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antiarrhythmic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROCAN SR TABLETS | 00638692 | Cancelled Post Market |
| PROCAN SR TABLETS | 00638676 | Cancelled Post Market |
| PROCAN SR TABLETS | 00638684 | Cancelled Post Market |
Medicinal ingredients
- PROCAINAMIDE HCL 250 MG per TAB
- PROCAINAMIDE HCL 500 MG per TAB
- PROCAINAMIDE HCL 750 MG per TAB